1. Home
  2. CMPS vs QUAD Comparison

CMPS vs QUAD Comparison

Compare CMPS & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • QUAD
  • Stock Information
  • Founded
  • CMPS 2020
  • QUAD 1971
  • Country
  • CMPS United Kingdom
  • QUAD United States
  • Employees
  • CMPS N/A
  • QUAD N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • QUAD Publishing
  • Sector
  • CMPS Health Care
  • QUAD Consumer Discretionary
  • Exchange
  • CMPS Nasdaq
  • QUAD Nasdaq
  • Market Cap
  • CMPS 322.5M
  • QUAD 287.7M
  • IPO Year
  • CMPS 2020
  • QUAD 2010
  • Fundamental
  • Price
  • CMPS $2.79
  • QUAD $5.53
  • Analyst Decision
  • CMPS Strong Buy
  • QUAD Strong Buy
  • Analyst Count
  • CMPS 7
  • QUAD 2
  • Target Price
  • CMPS $21.83
  • QUAD $10.15
  • AVG Volume (30 Days)
  • CMPS 1.0M
  • QUAD 223.6K
  • Earning Date
  • CMPS 05-07-2025
  • QUAD 04-29-2025
  • Dividend Yield
  • CMPS N/A
  • QUAD 4.09%
  • EPS Growth
  • CMPS N/A
  • QUAD N/A
  • EPS
  • CMPS N/A
  • QUAD N/A
  • Revenue
  • CMPS N/A
  • QUAD $2,672,200,000.00
  • Revenue This Year
  • CMPS N/A
  • QUAD N/A
  • Revenue Next Year
  • CMPS N/A
  • QUAD N/A
  • P/E Ratio
  • CMPS N/A
  • QUAD N/A
  • Revenue Growth
  • CMPS N/A
  • QUAD N/A
  • 52 Week Low
  • CMPS $2.69
  • QUAD $4.06
  • 52 Week High
  • CMPS $10.31
  • QUAD $9.13
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 31.50
  • QUAD 42.51
  • Support Level
  • CMPS $2.88
  • QUAD $5.29
  • Resistance Level
  • CMPS $3.16
  • QUAD $5.58
  • Average True Range (ATR)
  • CMPS 0.21
  • QUAD 0.16
  • MACD
  • CMPS -0.03
  • QUAD 0.04
  • Stochastic Oscillator
  • CMPS 9.30
  • QUAD 52.17

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.

Share on Social Networks: